A carregar...
The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
Colon cancer is currently the third most common cancer and second most fatal cancer in the United States, resulting in approximately 600,000 deaths annually. Though colorectal cancer death rates are decreasing by about 3% every year, disease outcomes could be substantially improved with more researc...
Na minha lista:
| Publicado no: | J Biomed Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial Department of Journal of Biomedical Research
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138576/ https://ncbi.nlm.nih.gov/pubmed/27924065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.30.20150109 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|